the staff of the Ridgewood blog
Ridgewood NJ, The Valley Hospital participated in a landmark clinical trial that evaluated the ability of a novel, fully absorbable antibacterial envelope – the Medtronic TYRX™ Absorbable Antibacterial Envelope – to reduce infections associated with cardiac implantable electronic devices (CIEDs). The study found positive results and demonstrated that the envelope reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, in patients at increased risk for infections receiving CIEDs, compared to standard-of-care pre-operative antibiotics.
The trial results were recently presented in a late-breaking session at the American College of Cardiology’s 68th Annual Scientific Sessions and published in The New England Journal of Medicine. Suneet Mittal, M.D., FACC, FHRS, Director, Electrophysiology, Valley Medical Group; Associate Chair, Cardiovascular Services, Valley Medical Group; Medical Director, The Snyder Center for Comprehensive Atrial Fibrillation, The Valley Hospital; and Director, Cardiac Research, Valley Health System, is one of the authors on the manuscript just published in the New England Journal of Medicine and served on the steering committee of the WRAP-IT trial.
Continue reading The Valley Hospital Participates in Landmark Global Cardiac Clinical Trial
